Multidrug-resistant Gram-negative bacteria: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "== Management == * Ceftolozane-tazobactam ** * Ceftazidime-avibactam ** Special Access Program * Fosfomycin ** * Colistin ** * Cefiderocol ** Special A..." |
(No difference)
|
Revision as of 13:07, 26 August 2020
Management
- Ceftolozane-tazobactam
- Ceftazidime-avibactam
- Special Access Program
- Fosfomycin
- Colistin
- Cefiderocol
- Special Access Program as well as preapproval by manufacturer
- Meropenem-vaborbactam
- Awaiting Health Canada Drug Review
- Imipenem-relebactam
- Really imipenem-cilastatin-relebactam
- Awaiting Health Canada Drug Review
